XML 20 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income $ 71,376,000 $ 61,643,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Tax benefit from stock-based compensation 10,763,000 11,109,000
Depreciation and amortization 737,000 (14,000)
Loss/(gain) on disposal of fixed assets 4,050,000 0
Impairment of intangible 2,000 2,001,000
Deferred taxes (21,000) (24,000)
Accrued interest on note receivable - related party 11,608,000 10,235,000
Deferred rent benefit 0 (306,000)
Marketable Securities, Realized Gain (Loss) (5,000) (182,000)
Changes, net of acquisitions, in:    
Accounts receivable 3,909,000 (37,000)
Factor accounts receivable (43,832,000) (44,372,000)
Notes receivable - related party (8,873,000) (23,303,000)
Repayment of Notes Receivable from Related Parties 204,000 205,000
Inventories (7,849,000) 11,182,000
Prepaid expenses, prepaid taxes, deposits and other 26,232,000 38,092,000
Increase (Decrease) in Employee Related Liabilities (4,974,000) (6,278,000)
Increase (Decrease) in Other Accrued Liabilities (1,449,000) (15,388,000)
Net cash provided by operating activities 59,761,000 44,927,000
Net benefit in connection with reversal of contingent liability partially offset by acceleration of amortization related to Kate Spade license termination (1,868,000) 0
Provision for Doubtful Accounts (259,000) 0
Cash flows from investing activities:    
Capital expenditures (6,214,000) (5,251,000)
Purchases of marketable securities (37,426,000) (41,738,000)
Repayment of notes receivable 69,488,000 66,634,000
Acquisitions, net of cash acquired 0 0
Net cash provided by investing activities 25,848,000 19,645,000
Cash flows from financing activities:    
Proceeds from exercise of stock options (51,156,000) (35,102,000)
Payments of Dividends (23,987,000) (23,474,000)
Tax benefit from the exercise of options 1,799,000 11,115,000
business combinations contingent liability payment 0 7,000,000
Net cash (used in) financing activities (73,174,000) (54,461,000)
Effect of Exchange Rate on Cash and Cash Equivalents 198,000 (340,000)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 1,283,000 0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (1,113,000) 0
Net increase in cash and cash equivalents 12,633,000 9,771,000
Cash and cash equivalents – beginning of period 200,031,000 181,214,000
Cash and cash equivalents – end of period $ 212,664,000 $ 190,985,000